Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
Development of colorectal cancer occurs via a number of key pathways, with the clinicopathological features of specific subgroups being driven by underlying molecular changes. Mutations in key genes within the network of signalling pathways have been identified; however, therapeutic strategies to ta...
Main Authors: | Graham, Donna M., Coyle, Vicky M., Kennedy, Richard D., Wilson, Richard H. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer US
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879165/ |
Similar Items
-
The Consensus Molecular Subtypes of Colorectal Cancer
by: Guinney, Justin, et al.
Published: (2015) -
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
by: Le Du, Fanny, et al.
Published: (2015) -
Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy
by: Wang, Lisha, et al.
Published: (2014) -
Molecularly targeted drugs for metastatic colorectal cancer
by: Cheng, Ying-dong, et al.
Published: (2013) -
Role of targeted therapy in metastatic colorectal cancer
by: Ohhara, Yoshihito, et al.
Published: (2016)